Like Aβ, hyperphosphorylated tau has been detected in the brains of individuals with AD; therefore, protein kinase inhibitors can play an important role to reduce AD by primarily targeting pathogenic tau [163, 164]. Here, MAPT is linked to Alzheimer disease.